Real-time US stock institutional ownership tracking and fund flow analysis to understand who owns and is buying the stock. We monitor 13F filings and institutional buying patterns because large investors often have superior information.
Burning Rock Biotech Limited American Depositary Shares (BNR) is trading at $17.0 as of 2026-05-01, notching a 4.68% gain on the day amid mild positive sentiment across the broader biotech sector. This analysis outlines key technical levels, recent market context, and potential scenarios for BNR in upcoming trading sessions, with a focus on observed support and resistance thresholds that have shaped recent price action. As a developer of precision oncology diagnostics and therapeutics, BNR’s pri
Which countries contribute most to Burning Rock (BNR) revenue? (Overhead Buying) 2026-05-01 - Macro Trends
BNR - Stock Analysis
4575 Comments
1990 Likes
1
Jazzy
Trusted Reader
2 hours ago
How do you make it look this easy? 🤔
👍 169
Reply
2
Premier
Insight Reader
5 hours ago
If only I had spotted this sooner.
👍 186
Reply
3
Khloi
Senior Contributor
1 day ago
Who else is curious about this?
👍 35
Reply
4
Eual
New Visitor
1 day ago
Market action today reflects a cautious but positive outlook, with indices consolidating after recent gains. Intraday swings are moderate, indicating measured investor behavior. Analysts note that sustainable momentum will depend on volume and breadth metrics in the coming sessions.
👍 80
Reply
5
Reis
Senior Contributor
2 days ago
This feels like an unfinished sentence.
👍 243
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.